Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate-specific Membrane Antigen”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Early research (Phase 1)Study completedNCT05441501
What this trial is testing

JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 39
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Early research (Phase 1)Looking for participantsNCT07082920
What this trial is testing

JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 140
Not applicableStudy completedNCT05819606
What this trial is testing

Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 70
Not applicableLooking for participantsNCT06209853
What this trial is testing

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Who this might be right for
Prostatic Neoplasms
Assiut University 59
Not applicableUnknownNCT05995236
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Who this might be right for
Prostate Cancer
Methodist Health System 400
Testing effectiveness (Phase 2)Study completedNCT04936334
What this trial is testing

The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer

Who this might be right for
Prostate Cancer
Clinton Bahler 51
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 65
Not applicableStudy completedNCT03857087
What this trial is testing

68Ga-PSMA PET in Diagnosing Metastasis in Patients With Ovarian Cancer

Who this might be right for
Ovarian Carcinoma
University of California, San Francisco 7
Testing effectiveness (Phase 2)Ended earlyNCT05489991
What this trial is testing

TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Tceleron Therapeutics, Inc. 1
Testing effectiveness (Phase 2)Looking for participantsNCT05155046
What this trial is testing

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy

Who this might be right for
Localized Prostate Cancer
National Cancer Institute (NCI) 130
Not applicableLooking for participantsNCT06690970
What this trial is testing

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Who this might be right for
PSMA-related DiseaseProstate CancerPositron Emission Tomography+2 more
Tianjin Medical University 500
Early research (Phase 1)Study completedNCT00712829
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Who this might be right for
Prostate Cancer
Molecular Insight Pharmaceuticals, Inc. 12
Early research (Phase 1)UnknownNCT04839991
What this trial is testing

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 70
Testing effectiveness (Phase 2)Looking for participantsNCT06004661
What this trial is testing

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 20
Early research (Phase 1)Study completedNCT03427476
What this trial is testing

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Cancer Targeted Technology 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT07047118
What this trial is testing

JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals 134
Not applicableUnknownNCT03507595
What this trial is testing

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer MetastaticProstate Cancer Recurrent+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05570994
What this trial is testing

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer MetastaticCastrate Resistant Prostate Cancer
British Columbia Cancer Agency 50
Load More Results